CEO and co-founder
Nagi Bioscience, Switzerland
Dr. Matteo Cornaglia is CEO and co-founder of Nagi Bioscience. Entrepreneur and engineer with an international education and a strong multidisciplinary profile, Matteo owns 12+ years of expertise in the development of microfluidic-based solutions for biology research and 5+ years of experience in startup development. He holds a PhD in Microsystems from the Swiss Federal Institute of Technology Lausanne (EPFL) and a Master in Nanotechnologies as a joint study agreement between Polytechnic University of Turin, Grenoble Institute of Technology, EPFL, and the Lawrence Berkeley National Lab. He is the main inventor of Nagi’s technology and owns 25+ scientific publications and 2 patents in the field, and received certifications, grants and awards from top institutions at national and international level, incl. e.g. the European Research Council (ERC), the Swiss Innovation Agency (Innosuisse), and the International Institute for Management Development (IMD school).
SydLab™ One: in vivo testing at the in vitro scale
Wednesday, May 24, 2023
14:15 – 14:30 CET